Healio, July 22, 2015. “We have a conflict between what we know logically should work [and] data that … just aren’t very good,” panel member Diana Zuckerman, PhD, president of the National Center for Health Research Cancer Prevention and Treatment Fund, said. She was one of several panelists who emphasized the need for more long-term data.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
After Health Care Act, Sharp Drop in Spending on Birth Control
The New York Times, July 7, 2015. Out-of-pocket spending on most major birth control methods fell sharply in the months after the Affordable Care Act began requiring insurance plans to cover contraception at no cost to women, a new study has found.
Read More »House Overwhelmingly Passes 21st Century Cures Act
Modern Healthcare, July 10, 2015. In a rare act of bipartisanship, House members voted 344-77 on Friday in favor of the 21st Century Cures Act, which supporters say will speed the development and regulatory approval of medical breakthroughs. Critics say that speed would come at the expense of patients’ safety.
Read More »Hope For Children’s Rare Drug Approval Process
USA Today (Kaiser Health News), June 7, 2015. A reward program is an extension of the 21st Century Cures bill, which seeks to rewrite the rules for drug development to make innovative treatments available faster.
Read More »FDA Reviewing Safety of Essure Birth Control Implant
The Associated Press, June 25, 2015. Federal health regulators are reviewing the safety of an implantable contraception device after receiving reports of unusual side effects from patients, including fatigue, depression and weight gain.
Read More »